We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Challenge to Reduce Sexually Transmitted Disease Infections Spurs Growth in IVD Sector

By LabMedica International staff writers
Posted on 20 Dec 2015
Print article
Nearly one out of every five dollars earned in infectious disease testing is from a test for sexually transmitted infections (STIs) or women’s health test, according to a new healthcare market research report.

In its new analysis, “The World Market for Infectious Disease Testing,” Kalorama Information (New York, NY, USA) reported that responding to resilient and rebounding rates of STIs and the increasing specialization in medicine to optimally treat female patients and conditions, many in the IVD industry have prioritized assay menus in those areas across platforms, foremost in molecular diagnostics. Still, a diverse range of IVD products are used to for screening and assessment, including cultures, laboratory immunoassays, rapid immunoassays, molecular assays, and high-throughput blood screening assays.

“With consistent national reporting in the United States, it has become apparent that STIs have rebounded from reported historical lows and been resilient to eradication goals,” said Emil Salazar, Kalorama IVD analyst.

Within IVD, infectious disease tests for STIs and women’s health typically do not include diagnostics for HIV or viral hepatitis, which independently represent multi-billion-dollar markets. The most significant pathogens in STI and women’s health testing include Chlamydia (CT), gonorrhea (NG), syphilis, ToRCH panel pathogens, and human papillomavirus (HPV). The infections are highly impactful to community health, maternal health, and prenatal and neonatal health.

Chlamydia has been on the rise since reporting began in the US. Gonorrhea declined nearly 75% between 1975–1997, but thereafter remained roughly constant through 2009 before rising slightly every year through 2012. Syphilis , after declining nearly 90% between 1990-2000, reached its lowest rate in the US since reporting began in 1941. The dramatic decline of syphilis and the regional concentration of the disease lead the Surgeon General to release a national eradication plan in 1999, updated in 2006. However, syphilis rate subsequently increased each year from 2001 to 2009 and jumped another 22% between 2011–2013.

In some cases, the observed increases in STIs may be a result of improved screening and reporting efforts rather than an actual groundswell in infections. Among sexually active US women aged 16–24 years with commercial insurance plans, Chlamydia screening nearly doubled between 2001-2012 to 45%. Increased Chlamydia screening has also impacted gonorrhea reporting as multiplex CT/NG testing is highly common.

“While truly rising STI incidence in the US is debatable, the above trends are nonetheless positive for the IVD industry since STI screening is becoming more commonplace in healthcare given an ongoing emphasis upon preventative care and improving national insurance coverage,” said Salazar.

Related Links:

Kalorama Information 
World Market for Infectious Disease Testing, report


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.